SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-98455"
 

Search: onr:"swepub:oai:DiVA.org:umu-98455" > Circulating Estroge...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Arslan, Alan A. (author)

Circulating Estrogen Metabolites and Risk of Breast Cancer in Postmenopausal Women

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • 2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-98455
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-98455URI
  • https://doi.org/10.1158/1055-9965.EPI-14-0009DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: It has been hypothesized that predominance of the 2-hydroxylation estrogen metabolism pathway over the 16 alpha-hydroxylation pathway may be inversely associated with breast cancer risk. Methods: We examined the associations of invasive breast cancer risk with circulating 2-hydroxyestrone (2-OHE1), 16 alpha-hydroxyestrone (16 alpha-OHE1), and the 2-OHE1: 16 alpha-OHE1 ratio in a case-control study of postmenopausal women nested within two prospective cohorts: the New York University Women's Health Study (NYUWHS) and the Northern Sweden Mammary Screening Cohort (NSMSC), with adjustment for circulating levels of estrone, and additional analyses by tumor estrogen receptor (ER) status. Levels of 2-OHE1 and 16 alpha-OHE1 were measured using ESTRAMET 2/16 assay in stored serum or plasma samples from 499 incident breast cancer cases and 499 controls, who were matched on cohort, age, and date of blood donation. Results: Overall, no significant associations were observed between breast cancer risk and circulating levels of 2-OHE1, 16 alpha-OHE1, or their ratio in either cohort and in combined analyses. For 2-OHE1, there was evidence of heterogeneity by ER status in models adjusting for estrone (P <= 0.03). We observed a protective association of 2-OHE1 with ER + breast cancer [multivariate-adjusted OR for a doubling of 2-OHE1, 0.67 (95% confidence interval [CI], 0.48-0.94; P = 0.02)]. Conclusions: In this study, higher levels of 2-OHE1 were associated with reduced risk of ER + breast cancer in postmenopausal women after adjustment for circulating estrone. Impact: These results suggest that taking into account the levels of parent estrogens and ER status is important in studies of estrogen metabolites and breast cancer.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Koenig, Karen L. (author)
  • Lenner, PerUmeå universitet,Onkologi(Swepub:umu)pele0005 (author)
  • Afanasyeva, Yelena (author)
  • Shore, Roy E. (author)
  • Chen, Yu (author)
  • Lundin, EvaUmeå universitet,Institutionen för medicinsk biovetenskap(Swepub:umu)evlu0001 (author)
  • Toniolo, Paolo (author)
  • Hallmans, GöranUmeå universitet,Enheten för biobanksforskning,Näringsforskning(Swepub:umu)goha0001 (author)
  • Zeleniuch-Jacquotte, AnneUmeå universitet,Enheten för biobanksforskning (author)
  • Umeå universitetOnkologi (creator_code:org_t)

Related titles

  • In:Cancer Epidemiology, Biomarkers and Prevention23:7, s. 1290-12971055-99651538-7755

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view